scholarly article | Q13442814 |
P2093 | author name string | Arvind K Bansal | |
Garima Chawla | |||
P2860 | cites work | Characterization of glass solutions of poorly water-soluble drugs produced by melt extrusion with hydrophilic amorphous polymers | Q28216525 |
Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards | Q33935245 | ||
The mechanisms of drug release from solid dispersions in water-soluble polymers | Q34469709 | ||
Impact of solid state properties on developability assessment of drug candidates | Q35666932 | ||
Pharmaceutical Applications of Solid Dispersion Systems | Q40000294 | ||
Enhancement of dissolution profile by solid dispersion (kneading) technique | Q41919742 | ||
Physicochemical considerations in the preparation of amorphous ritonavir-poly(ethylene glycol) 8000 solid dispersions | Q43728317 | ||
Phase behaviour analysis of solid dispersions of loperamide and two structurally related compounds with the polymers PVP-K30 and PVP-VA64. | Q44986942 | ||
Solubilization of two structurally related anticancer drugs: XK-469 and PPA. | Q46825697 | ||
A comparative assessment of solubility advantage from glassy and crystalline forms of a water-insoluble drug. | Q51910844 | ||
P433 | issue | 3 | |
P304 | page(s) | 257-274 | |
P577 | publication date | 2008-09-01 | |
P1433 | published in | Acta Pharmaceutica | Q15758179 |
P1476 | title | Improved dissolution of a poorly water soluble drug in solid dispersions with polymeric and non-polymeric hydrophilic additives | |
P478 | volume | 58 |
Q39151241 | Formulation and development of a self-nanoemulsifying drug delivery system of irbesartan |
Q42933120 | Multicomponent amorphous nanofibers electrospun from hot aqueous solutions of a poorly soluble drug |
Q38798931 | Nanostructured DPA-MPC-DPA triblock copolymer gel for controlled drug release of ketoprofen and spironolactone. |
Q41110630 | Pediatric suppositories of sulpiride solid dispersion for treatment of Tourette syndrome: in vitro and in vivo investigations. |
Q58032213 | Pharmaceutical Dispersion Techniques for Dissolution and Bioavailability Enhancement of Poorly Water-Soluble Drugs |
Search more.